双亚型猫免疫缺陷病毒疫苗（Fel-O-Vax FIV）对异源B亚型猫免疫缺陷病毒分离株的保护作用。
Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate.
作者信息
Pu Ruiyu, Coleman James, Coisman James, Sato Eiji, Tanabe Taishi, Arai Maki, Yamamoto Janet K
机构信息
Department of Pathobiology, College of Veterinary Medicine, University of Florida, P.O. Box 110880, Gainesville, FL 32611-0880, USA.
出版信息
J Feline Med Surg. 2005 Feb;7(1):65-70. doi: 10.1016/j.jfms.2004.08.005.
Abstract
Vaccine trials were undertaken to determine whether the Fel-O-Vax FIV, a commercial dual-subtype (subtypes A and D) feline immunodeficiency virus (FIV) vaccine, is effective against a subtype B FIV isolate. Current results demonstrate the Fel-O-Vax FIV to be effective against a subtype B virus, a subtype reported to be the most common in the USA.
摘要
进行了疫苗试验，以确定一种商业双亚型（A和D亚型）猫免疫缺陷病毒（FIV）疫苗Fel-O-Vax FIV是否对B亚型FIV分离株有效。目前的结果表明，Fel-O-Vax FIV对B亚型病毒有效，据报道该亚型是美国最常见的亚型。
相似文献
1
Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate.
J Feline Med Surg. 2005 Feb;7(1):65-70. doi: 10.1016/j.jfms.2004.08.005.
2
Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
Vet Microbiol. 2005 Jul 1;108(3-4):155-65. doi: 10.1016/j.vetmic.2005.02.014.
3
Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
AIDS. 1998 Jan 1;12(1):11-8. doi: 10.1097/00002030-199801000-00002.
4
Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies.
Vaccine. 2014 Feb 3;32(6):746-54. doi: 10.1016/j.vaccine.2013.05.024. Epub 2013 Jun 22.
5
Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 Vaccine.
Viruses. 2018 May 22;10(5):277. doi: 10.3390/v10050277.
6
Lack of protection against feline immunodeficiency virus infection among domestic cats in New Zealand vaccinated with the Fel-O-Vax® FIV vaccine.
Vet Microbiol. 2020 Nov;250:108865. doi: 10.1016/j.vetmic.2020.108865. Epub 2020 Sep 28.
7
Feline immunodeficiency virus model for designing HIV/AIDS vaccines.
Curr HIV Res. 2010 Jan;8(1):14-25. doi: 10.2174/157016210790416361.
8
Sequence variation of the feline immunodeficiency virus genome and its clinical relevance.
Vet Rec. 2013 Jun 8;172(23):607-14. doi: 10.1136/vr.f101460.
9
Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax FIV).
Viruses. 2021 Mar 12;13(3):470. doi: 10.3390/v13030470.
10
Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates.
AIDS. 2001 Jul 6;15(10):1225-37. doi: 10.1097/00002030-200107060-00004.
引用本文的文献
1
Feline immunodeficiency virus (FIV) infection in domestic pet cats in Australia and New Zealand: Guidelines for diagnosis, prevention and management.
Aust Vet J. 2022 Aug;100(8):345-359. doi: 10.1111/avj.13166. Epub 2022 May 16.
2
FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge.
NPJ Vaccines. 2018 Apr 30;3:16. doi: 10.1038/s41541-018-0051-y. eCollection 2018.
3
Applications of the FIV Model to Study HIV Pathogenesis.
Viruses. 2018 Apr 20;10(4):206. doi: 10.3390/v10040206.
4
First Molecular Characterization of Feline Immunodeficiency Virus in Domestic Cats from Mainland China.
PLoS One. 2017 Jan 20;12(1):e0169739. doi: 10.1371/journal.pone.0169739. eCollection 2017.
5
An investigation of the breadth of neutralizing antibody response in cats naturally infected with feline immunodeficiency virus.
J Gen Virol. 2015 Mar;96(Pt 3):671-680. doi: 10.1099/vir.0.071522-0. Epub 2014 Nov 13.
6
Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies.
Vaccine. 2014 Feb 3;32(6):746-54. doi: 10.1016/j.vaccine.2013.05.024. Epub 2013 Jun 22.
7
A door-to-door prevalence study of feline immunodeficiency virus in an Australian suburb.
J Feline Med Surg. 2013 Dec;15(12):1070-8. doi: 10.1177/1098612X13491959. Epub 2013 Jun 5.
8
Selective expansion of viral variants following experimental transmission of a reconstituted feline immunodeficiency virus quasispecies.
PLoS One. 2013;8(1):e54871. doi: 10.1371/journal.pone.0054871. Epub 2013 Jan 23.
9
Feline leukemia and feline immunodeficiency virus in Canada - A comment.
Can Vet J. 2012 Jan;53(1):9-10; author reply 10.
10
Feline leukemia virus and feline immunodeficiency virus in Canada: recommendations for testing and management.
Can Vet J. 2011 Aug;52(8):849-55.
本文引用的文献
1
Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine.
Vaccine. 2004 Dec 2;23(3):386-98. doi: 10.1016/j.vaccine.2004.05.032.
2
FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review.
Vet Immunol Immunopathol. 2002 Dec;90(3-4):113-32. doi: 10.1016/s0165-2427(02)00227-1.
3
Deluge of questions prompts AAFP to develop FIV vaccine brief. American Association of Feline Practitioners.
J Am Vet Med Assoc. 2002 Nov 1;221(9):1231-4.
4
Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates.
AIDS. 2001 Jul 6;15(10):1225-37. doi: 10.1097/00002030-200107060-00004.
5
Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus.
J Virol. 2000 Oct;74(20):9403-11. doi: 10.1128/jvi.74.20.9403-9411.2000.
6
MHC-restricted protection of cats against FIV infection by adoptive transfer of immune cells from FIV-vaccinated donors.
Cell Immunol. 1999 Nov 25;198(1):30-43. doi: 10.1006/cimm.1999.1574.
7
Vaccination of cats against feline immunodeficiency virus (FIV): a matter of challenge.
Vet Microbiol. 1999 Sep 1;69(1-2):109-10. doi: 10.1016/s0378-1135(99)00096-6.
8
Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection.
J Gen Virol. 1999 Mar;80 ( Pt 3):761-765. doi: 10.1099/0022-1317-80-3-761.
9
Feline bone marrow transplantation: its use in FIV-infected cats.
Vet Immunol Immunopathol. 1998 Oct 23;65(2-4):323-51. doi: 10.1016/s0165-2427(98)00165-2.
10
Perspectives on FIV vaccine development.
Vaccine. 1997 Aug-Sep;15(12-13):1437-44. doi: 10.1016/s0264-410x(97)00056-x.
Zotero 插件